Literature DB >> 18000757

Acromegaly and anaplastic astrocytoma: coincidence or pathophysiological relation?

Alberto Fernandez1, Niki Karavitaki, Olaf Ansorge, Violet Fazal-Sanderson, John A H Wass.   

Abstract

Insulin-like growth factor type I (IGF-I) is an important promoter in the tumorigenesis of several extracranial and intracranial neoplasms. In astrocytic-cell tumors, the role of autocrine and paracrine IGF-I expression in enhancing tumoral progression is well established. However, the influence of systemic IGF-I levels on the clinical behavior of astrocytic neoplasms remains an open subject of research. We report the case of a 28-year-old man who presented simultaneously with acromegaly and an anaplastic astrocytoma, which had rapidly progressed from a low-grade astrocytoma. The coexistence of systemic IGF-I hypersecretion with a quick progression in the histopathological grade of the astrocytoma raises the compelling question of whether the clinical behavior of the astrocytic tumor was influenced by the acromegalic status. The role of IGF-I signaling in the pathogenesis of astrocytic-cell tumors and the experience with therapeutic strategies addressing this pathway in astrocytomas are also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18000757     DOI: 10.1007/s11102-007-0074-2

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  31 in total

Review 1.  Insulin-like growth factors as mediators of functional plasticity in the adult brain.

Authors:  I Torres-Aleman
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

3.  Proliferative activity and prognosis of low-grade astrocytomas.

Authors:  D Schiffer; P Cavalla; A Chiò; P Richiardi; M T Giordana
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

4.  Suspected low-grade glioma: is deferring treatment safe?

Authors:  L D Recht; R Lew; T W Smith
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

5.  Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.

Authors:  D Yee; F R Morales; T C Hamilton; D D Von Hoff
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

Review 6.  Glioma occurrence after sellar irradiation: case report and review.

Authors:  N E Simmons; E R Laws
Journal:  Neurosurgery       Date:  1998-01       Impact factor: 4.654

7.  Prognostic factors for survival in adult patients with cerebral low-grade glioma.

Authors:  Francesco Pignatti; Martin van den Bent; Desmond Curran; Channa Debruyne; Richard Sylvester; Patrick Therasse; Denes Afra; Philippe Cornu; Michel Bolla; Charles Vecht; Abul B M F Karim
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

Review 8.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

9.  Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.

Authors:  M Resnicoff; C Sell; M Rubini; D Coppola; D Ambrose; R Baserga; R Rubin
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

Review 10.  Central effects of the somatotropic system.

Authors:  Harald Jörn Schneider; Uberto Pagotto; Günter Karl Stalla
Journal:  Eur J Endocrinol       Date:  2003-11       Impact factor: 6.664

View more
  2 in total

1.  Prolactinoma associated with an ependymoma in the fourth ventricle: A case report and review of the literature.

Authors:  Jinlu Yu; Hongfa Yang; Limei Qu; Yunqian Li
Journal:  Oncol Lett       Date:  2015-05-12       Impact factor: 2.967

2.  Genetic analysis in a patient presenting with meningioma and familial isolated pituitary adenoma (FIPA) reveals selective involvement of the R81X mutation of the AIP gene in the pathogenesis of the pituitary tumor.

Authors:  Federica Guaraldi; Valentina Corazzini; Gary L Gallia; Silvia Grottoli; Karen Stals; Nadezhda Dalantaeva; Lawrence A Frohman; Márta Korbonits; Roberto Salvatori
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.